Poster 7
- Jun 28, 2023
- 1 min read
Efficacy of Deuruxolitinib Across Subgroups of Patients with Severe Alopecia Areata by Demographic and Baseline Characteristics: Pooled Analysis of the THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
Maryanne M. Senna, MD; Brett King, MD, PhD; Natasha A. Mesinkovska, MD, PhD; Arash Mostaghimi, MD, MPH; Heidi Goldstein, MA; Yasmin Mathlin, MD, DNP, DCNP; Kizito Kyeremateng, PharmD; Nicholas Squittieri, MD


